3-三氟甲基苯基叠氮化物 | 22001-17-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-三氟甲基苯基叠氮化物
• 英文名称: 3-trifluoromethylphenylazide
• 英文别名: 1-azido-3-(trifluoromethyl)benzene
• CAS: 22001-17-8
• 化学式: C₇H₄F₃N₃
• mdl: MFCD11207355
• 分子量: 187.124
• InChiKey: GIDLBMJGNCUXLD-UHFFFAOYSA-N

物化性质

• 沸点：
  51 °C(Press: 8.5 Torr)
• 闪点：
  -33℃

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  14.4
• 氢给体数：
  0
• 氢受体数：
  5

安全信息

• 海关编码：
  2929909090

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : 1-Azido-3-(trifluoromethyl)benzene solution
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Flammable liquids (Category 2), H225
Skin irritation (Category 2), H315
Eye irritation (Category 2), H319
Specific target organ toxicity - repeated exposure (Category 1), H372
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
F Highly flammable R11
T Toxic R48/23/24/25
Xi Irritant R38
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Danger
Hazard statement(s)
H225 Highly flammable liquid and vapour.
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H372 Causes damage to organs through prolonged or repeated exposure.
Precautionary statement(s)
P210 Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
P314 Get medical advice/ attention if you feel unwell.
Supplemental Hazard none
Statements
According to European Directive 67/548/EEC as amended.
Hazard symbol(s) F Highly flammable
T Toxic
R-phrase(s)
R11 Highly flammable.
R38 Irritating to skin.
R48/23/24/25 Toxic: danger of serious damage to health by prolonged exposure
through inhalation, in contact with skin and if swallowed.
S-phrase(s)
S16 Keep away from sources of ignition - No smoking.
Other hazards - none

---

SECTION 3: Composition/information on ingredients
Mixtures
Synonyms : 3-(Trifluoromethyl)phenyl azide solution
m-Azido-α,α,α-trifluorotoluene solution
Molecular Weight : 187,12 g/mol
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
tert-Butyl methyl ether
CAS-No. 1634-04-4 Flam. Liq. 2; Skin Irrit. 2; 50 - 100 %
EC-No. 216-653-1 H225, H315
Index-No. 603-181-00-X
1-Azido-3-(trifluoromethyl)benzene
CAS-No. 22001-17-8 Self-react. B; Skin Irrit. 2; Eye 10 - 20 %
Irrit. 2; STOT SE 3; STOT RE
1; H241, H315, H319, H335,
H372
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
tert-Butyl methyl ether
CAS-No. 1634-04-4 F, Xi, R11 - R38 50 - 100 %
EC-No. 216-653-1
Index-No. 603-181-00-X
1-Azido-3-(trifluoromethyl)benzene
CAS-No. 22001-17-8 T, R 5 - R36/37/38 - 10 - 20 %
R48/23/24/25
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

---

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Take victim immediately to hospital. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Do NOT induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with
water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx), Hydrogen fluoride
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
Use water spray to cool unopened containers.

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid breathing vapours, mist or gas. Ensure adequate ventilation.
Remove all sources of ignition. Evacuate personnel to safe areas. Beware of vapours accumulating to
form explosive concentrations. Vapours can accumulate in low areas.
For personal protection see section 8.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
Methods and materials for containment and cleaning up
Contain spillage, and then collect with an electrically protected vacuum cleaner or by wet-brushing and
place in container for disposal according to local regulations (see section 13).
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist.
Keep away from sources of ignition - No smoking.Take measures to prevent the build up of electrostatic
charge.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
opened must be carefully resealed and kept upright to prevent leakage.
Recommended storage temperature: -20 °C
Light sensitive.
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under
appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Splash contact
Material: Nitrile rubber
Minimum layer thickness: 0,4 mm
Break through time: 120 min
Material tested:Camatril® (KCL 730 / Z677442, Size M)
data source: KCL GmbH, D-36124 Eichenzell, phone [phone], test method: EN374
If used in solution, or mixed with other substances, and under conditions which differ from EN 374,
contact the supplier of the CE approved gloves. This recommendation is advisory only and must
be evaluated by an industrial hygienist and safety officer familiar with the specific situation of
anticipated use by our customers. It should not be construed as offering an approval for any
specific use scenario.
Body Protection
Complete suit protecting against chemicals, Flame retardant antistatic protective clothing, The type
of protective equipment must be selected according to the concentration and amount of the
dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator
with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup
to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air
respirator. Use respirators and components tested and approved under appropriate government
standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: clear, liquid
Colour: colourless
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
Heat, flames and sparks. Extremes of temperature and direct sunlight.
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: 3 - Group 3: Not classifiable as to its carcinogenicity to humans (tert-Butyl methyl ether)
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Central nervous system - (tert-Butyl methyl ether)

---

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Burn in a chemical incinerator equipped with an afterburner and scrubber but exert extra care in igniting
as this material is highly flammable. Offer surplus and non-recyclable solutions to a licensed disposal
company.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: 2398 IMDG: 2398 IATA: 2398
UN proper shipping name
ADR/RID: METHYL tert-BUTYL ETHER, SOLUTION
IMDG: METHYL tert-BUTYL ETHER, SOLUTION
IATA: Methyl tert-butyl ether, SOLUTION
Transport hazard class(es)
ADR/RID: 3 IMDG: 3 IATA: 3
Packaging group
ADR/RID: II IMDG: II IATA: II
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
For this product a chemical safety assessment was not carried out

---

SECTION 16: Other information
Full text of H-Statements referred to under sections 2 and 3.
Eye Irrit. Eye irritation
Flam. Liq. Flammable liquids
H225 Highly flammable liquid and vapour.
H241 Heating may cause a fire or explosion.
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
H372 Causes damage to organs through prolonged or repeated exposure.
Self-react. Self reactive substances
Skin Irrit. Skin irritation
STOT RE Specific target organ toxicity - repeated exposure
STOT SE Specific target organ toxicity - single exposure
Full text of R-phrases referred to under sections 2 and 3
F Highly flammable
T Toxic
R5 Heating may cause an explosion.
R11 Highly flammable.
R36/37/38 Irritating to eyes, respiratory system and skin.
R38 Irritating to skin.
R48/23/24/25 Toxic: danger of serious damage to health by prolonged exposure through inhalation,
in contact with skin and if swallowed.
Xi Irritant
Further information
Copyright 2014 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

反应信息

• 作为反应物：
  描述：

  3-三氟甲基苯基叠氮化物 在 lithium aluminium tetrahydride 、 三溴化磷 、 sodium hydride 、 copper(II) sulfate 、 sodium ascorbate 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 为溶剂， 反应 49.5h， 生成
  参考文献：
  名称：

  设计，合成和具有15、11、2、3-三唑侧链的11a-azahomoclarithromycin衍生物的抗菌评估。

  摘要：

  临床上广泛使用大环内酯类药物来治疗各种呼吸道感染。然而，由于它们的不当使用，临床分离株中大环内酯类耐药菌株的流行已成为公共卫生的关注点。因此，迫切需要新型的抗病原体大环内酯类骨架结构。因此，通过创造性地打开克拉霉素（CAM）的环，适当地扩环并引入环戊基，设计并合成了具有1，2，2，3-三唑侧链的三个系列的新型15元11a-azahomoclarithromycin衍生物（AC系列）。在C12和C13位置的1，2，3-三唑合适的侧链，并评估其抗菌活性。抗菌结果表明，化合物38b，38l和38v对金黄色葡萄球菌ATCC25923（0.25μg/ mL）和枯草芽孢杆菌ATCC9372（0.25μg/ mL）具有很强的抗菌活性。此外，发现化合物9e和38g对表达ermB和mefA基因的肺炎链球菌AB11表现出有希望的有效活性（8μg/ mL）。另外，最小杀菌浓度（MBC）的测定表明，最有希望的化合

  DOI：

  10.1016/j.ejmech.2019.07.022
• 作为产物：
  描述：

  tetrafluoroborate of 3-trifluoromethylbenzenediazonium 在 盐酸羟胺 作用下， 以 水 为溶剂， 反应 24.0h， 以60%的产率得到3-三氟甲基苯基叠氮化物
  参考文献：
  名称：

  前所未有的简单方法合成芳基叠氮化物和3-羟基三氮烯

  摘要：

  费舍尔从重氮盐和氯化铵氯化物（苯基羟胺）合成芳基叠氮化物和三嗪类的方法进行了重新研究和优化。新的方法可以制备芳基叠氮化物和...

  DOI：

  10.1039/c6gc02379g

文献信息

• Studies on Synthesis of Novel Triazole Tagged Pyrazole Fused Naphthalene 5-Thiazine-5,5-dioxide Derivatives, Their Antimicrobial, and Antioxidant Activity
  作者：G. Malla Reddy、P. Nagender、R. Naresh Kumar、J. H. Ahn、K. Pranay Kumar、A. K. R. Kanugula、K. V. S. Rama Krishna、S. Kotamraju、B. Narsaiah

  DOI：10.1002/jhet.2013

  日期：2014.8

  A series of novel triazole tagged pyrazole fused naphthalene-5-thiazine-5,5-dioxide derivatives and were synthesized starting from sodium salt of saccharin . The structure of each intermediate and products was established on the basis of spectroscopy data. All the synthesized compounds and were screened against various bacterial and fungal strains but found to show no activity up to 150-µg/mL concentration

  一系列新型的三唑标记的吡唑稠合萘-5-噻嗪-5,5-二氧化物衍生物 和 从糖精钠盐开始合成 。根据光谱数据确定每种中间体和产物的结构。所有合成的化合物 和 对各种细菌和真菌菌株进行了筛选，但发现在浓度高达150 µg / mL时无活性。进一步筛选抗氧化剂性能得到了有希望的化合物。
• Thermal azide–alkene cycloaddition reactions: straightforward multi-gram access to Δ²-1,2,3-triazolines in deep eutectic solvents
  作者：Filip Sebest、Luis Casarrubios、Henry S. Rzepa、Andrew J. P. White、Silvia Díez-González

  DOI：10.1039/c8gc01797b

  日期：——

  The multi-gram synthesis of a wide range of 1,2,3-triazolines via azide–alkene cycloaddition reactions in a Deep Eutectic Solvent (DES) is reported. The role of DES in this transformation as well as the origin of the full product distribution was studied with an experimental/computational-DFT approach.

  据报道，在深共晶溶剂（DES）中通过叠氮化物-烯烃环加成反应可以合成多种1,2,3-三唑啉。使用实验/计算-DFT方法研究了DES在这种转变中的作用以及整个产品分销的起源。
• Base-mediated reaction of vinyl bromides with aryl azides: one-pot synthesis of 1,5-disubstituted 1,2,3-triazoles
  作者：Luyong Wu、Yuxue Chen、Jianheng Luo、Qi Sun、Mingsheng Peng、Qiang Lin

  DOI：10.1016/j.tetlet.2014.03.029

  日期：2014.7

  been investigated in the process. A variety of 1,5-disubstituted triazoles were prepared in low to good yields. Further studies reveal that the corresponding alkynes were produced as intermediates via elimination reaction. Under the same reaction conditions, the reactions of alkyl alkynes with phenyl azide would give 1,5-disubstituted 1,2,3-triazoles.

  已经报道了叠氮化物与β-或α-乙烯基溴的一锅碱基介导的反应。在此过程中已研究了碱和溶剂的作用。各种1,5-二取代的三唑以低到好收率的方式制备。进一步的研究表明，相应的炔烃是通过消除反应生成的中间体。在相同的反应条件下，烷基炔烃与叠氮化苯的反应将生成1，5-二取代的1,2,3-三唑。
• Highly Efficient Rh(I) Homo- and Heterogeneous Catalysts for C–N Couplings via Hydrogen Borrowing
  作者：Chin M. Wong、Matthew B. Peterson、Indrek Pernik、Roy T. McBurney、Barbara A. Messerle

  DOI：10.1021/acs.inorgchem.7b02586

  日期：2017.12.4

  explored as catalysts for the hydrogen borrowing reactions of amines and alcohols. Bidentate carbene-triazole ligands were readily synthesized via “click” reactions which allowed a diversity of ligand backbones to be accessed. The catalytic transformations are highly efficient, able to reach completion in under 6 h, and promote C–N bond formation across a range of primary alcohol and amine substrates. Moreover

  研究了铑（I）配合物作为胺和醇的氢借入反应的催化剂。可以通过“点击”反应轻松合成二齿卡宾-三唑配体，从而可以使用各种配体骨架。催化转化是高效的，能够在6小时内完成，并促进了一系列伯醇和胺底物上C–N键的形成。此外，使用具有一个以上反应性位点的底物可以实现位点选择性催化。共价附于炭黑表面的铑（I）络合物也被部署在苯胺与苯甲醇的氢借位偶联反应中。这是用于氢借入的非均相铑催化剂的首次报道。
• 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists
  申请人：Life & Brain GmbH

  公开号：EP2465859A1

  公开（公告）日：2012-06-20

  The invention relates to derivatives of the general formulae I and II to processes for the production thereof, to pharmaceutical preparations containing said compounds and/or physiologically compatible salts, or solvates which can be produced therefrom as well as to the pharmaceutical use of said compounds, the salts, or solvates thereof as adenosine receptor antagonists, in particular for the treatment of neurodegenerative disorders, e.g. stroke, amylotrophic lateral sclerosis, dementia, Alzheimer's disease, Parkinson's disease, ischemia/reperfusion injury, inflammation, and/or neurological disorder. The blockade of adenosine receptors could also be useful for other indications regarding the metabolism, e.g. diabetic retinopathy, diabetes mellitus, hyperbaric oxygen-induced retinopathy and/or obesity. Applications could also be the treatment of allergic diseases and autoimmune diseases, including mast cell degranulation, asthma, bronchoconstriction, pulmonary fibrosis, inflammatory or obstructive airways disease and/or chronic obstructive pulmonary disease (COPD). In addition, they could be used to treat cancer, e.g. proliferating tumor, cell proliferation disorders, angiogenesis, lung cancer, breast cancer, pancreatic cancer, thyroid cancer, skin cancer, vascular endothelial cancer, cancer of the central nervous system, esophageal cancer, cancer of the larynx, gastrointestinal cancer, colon cancer, colorectal cancer, rectal cancer, liver cancer, renal cancer, prostate cancer, bladder cancer, cervical cancer, ovarian cancer, endometrial cancer, melanoma, squamous cell carcinoma, basal cell carcinoma, non-small cell lung cancer selected from squamous cell carcinoma, adenocarcinoma, large cell carcinoma, adenosquam- ous carcinoma and/or undifferentiated carcinoma. The diseases associated with adenosine receptors are also diabetes, diarrhea, inflammatory bowel disease and/or gastrointestinal tract disorders. Adenosine receptor antagonists could be effective for treating a hepatic disease or condition for reducing fat deposition in the liver or fibrosis of the liver. The use of compounds of general formulae I and II can be associated with many applications e.g., scleroderm arthritis, atherosclerosis, urticaria, myocardial infarction, myocardial reperfusion after ischemia, vasodilation, hypertension, hypersensitivity, myocardial ischemia, heart attack and/or retinopathy of prematurity.

  本发明涉及具有通用公式I和II的衍生物，以及它们的制备方法，包含所述化合物的药物制剂以及/或可以从它们产生的生理上相容的盐或溶剂化物，以及所述化合物、盐或溶剂化物作为腺苷受体拮抗剂的药物用途，特别是用于治疗神经退行性疾病，例如中风、肌萎缩侧索硬化、痴呆、阿尔茨海默病、帕金森病、缺血/再灌注损伤、炎症和/或神经系统疾病。腺苷受体的阻断还可能对其他与代谢有关的适应症有益，例如糖尿病视网膜病变、糖尿病、高氧引起的视网膜病变和/或肥胖。应用还可能是治疗过敏性疾病和自身免疫性疾病，包括肥大细胞脱粒、哮喘、支气管收缩、肺纤维化、炎症性或阻塞性气道疾病和/或慢性阻塞性肺病（COPD）。此外，它们还可用于治疗癌症，例如增殖性肿瘤、细胞增殖障碍、血管生成、肺癌、乳腺癌、胰腺癌、甲状腺癌、皮肤癌、血管内皮癌、中枢神经系统癌症、食管癌、喉癌、胃肠癌、结肠癌、结直肠癌、直肠癌、肝癌、肾癌、前列腺癌、膀胱癌、宫颈癌、卵巢癌、子宫内膜癌、黑色素瘤、鳞状细胞癌、基底细胞癌、非小细胞肺癌（包括鳞状细胞癌、腺癌、大细胞癌、腺鳞癌和/或未分化癌）。与腺苷受体相关的疾病还包括糖尿病、腹泻、炎症性肠病和/或胃肠道的疾病。腺苷受体拮抗剂可能对治疗肝脏疾病或状况有效，用于减少肝脏脂肪沉积或肝脏纤维化。通用公式I和II的化合物的使用可以与许多应用相关，例如，硬皮病关节炎、动脉粥样硬化、荨麻疹、心肌梗死、缺血后心肌再灌注、血管扩张、高血压、过敏反应、心肌缺血、心脏病发作和/或早产儿视网膜病变。